Related Experiment Video
Updated: Aug 23, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Severe pneumonia caused by human adenovirus type 55 in children
Dongwei Zhang1, Yi Chen2, Tingting Shi1
1Department of Respiratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Insights
Human adenovirus type 55 (HAdV-55) can cause fatal pneumonia in children, often with co-infections. This study highlights HAdV-55 as a significant cause of severe pediatric pneumonia and potential long-term complications like post-infectious bronchiolitis obliterans.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Respiratory Medicine
Background:
- Human adenovirus type 55 (HAdV-55) is an emerging pathogen causing severe pneumonia in adults.
- Limited research exists on HAdV-55's impact on pediatric severe pneumonia.
Purpose of the Study:
- To investigate the clinical characteristics and outcomes of severe pneumonia caused by HAdV-55 in children.
- To identify risk factors and complications associated with HAdV-55 pediatric pneumonia.
Main Methods:
- Retrospective review of pediatric patients with severe pneumonia from 2013-2020.
- Detection of human adenovirus (HAdV) using RT-PCR in respiratory samples.
- Identification of HAdV-55 by PCR amplification of hexon gene hypervariable regions.
Main Results:
- HAdV-55 was identified in 9 pediatric patients with severe (3) or critical (6) pneumonia, with no underlying conditions.
- Common symptoms included fever and cough; coinfections with bacteria, Mycoplasma pneumoniae, and fungi were frequent (6/9 patients).
- Critical cases experienced prolonged mechanical ventilation (median 10 days), high mortality (3/3), and complications including plastic bronchitis (PB) and post-infectious bronchiolitis obliterans (PIBO) in survivors.
Conclusions:
- HAdV-55 is a significant cause of severe and fatal pneumonia in previously healthy children.
- Coinfections and complications like PB and PIBO are associated with HAdV-55, indicating a poorer prognosis.
- HAdV-55 warrants attention as a critical pathogen in pediatric respiratory infections, particularly those leading to PIBO.
Background:
Emerging human adenovirus type 55 (HAdV-55) causes fatal pneumonia in adults. There is a lack of studies on severe pneumonia caused by HAdV-55 in children.
Methods:
We conducted a retrospective review of pediatric patients hospitalized at Guangzhou Women and Children's Medical Center with severe pneumonia from 2013 to 2020 who had human adenovirus (HAdV) detected in throat samples or bronchoalveolar lavage fluid using RT-PCR. The presence of HAdV-55 was determined by PCR amplification of the hypervariable regions of the hexon gene. Demographic, clinical, etiological, and outcome data were collected and analyzed.
Results:
Over the eight-year period, HAdV-55 was detected in three severe and six critical pediatric pneumonia patients. None of the patients had any underlying diseases, and had a median age of 18 months (range, 6-108 months). The male to female ratio was 2:1. All patients presented with fever and cough, and three patients presented with wheezing and diarrhea. Six patients had coinfections with other respiratory pathogens, such as bacteria, Mycoplasma pneumoniae and fungi. Three critical patients developed plastic bronchitis (PB). The median lengths of invasive mechanical ventilation and hospital stay of the critical patients were 10 (8, 28.75) days and 25 (13, 32.25) days, respectively. Three critical patients died, although two of them received extracorporeal membrane oxygenation (ECMO) and blood purification. Three surviving patients developed post-infectious bronchiolitis obliterans (PIBO) at the follow-up.
Conclusions:
HAdV-55 can cause fatal pneumonia in children, and shows a high rate of co-infection with other respiratory pathogens and a poorer prognosis combined with PB. Thus, HAdV-55 may be an important subtype in patients with HAdV-induced pneumonia who develop PIBO.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

